Hattori, Nobutaka

High-fat diet-induced activation of SGK1 promotes Alzheimer’s disease-associated tau pathology

Elahi, M., Motoi, Y., Shimonaka, S., Ishida, Y., Hioki, H., Takanashi, M., Ishiguro, K., Imai, Y., & Hattori, N. (2021) · Human Molecular Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 57

A Cell-Based High-Throughput Screening Identified Two Compounds that Enhance PINK1-Parkin Signaling

Shiba-Fukushima, K., Inoshita, T., Sano, O., Iwata, H., Ishikawa, K.-I., Okano, H., Akamatsu, W., Imai, Y., & Hattori, N. (2020) · iScience

Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and Therapy

Cited by 37

MR g-ratio-weighted connectome analysis in patients with multiple sclerosis

Kamagata, K., Zalesky, A., Yokoyama, K., Andica, C., Hagiwara, A., Shimoji, K., Kumamaru, K. K., Takemura, M. Y., Hoshino, Y., Kamiya, K., et al. (2019) · Scientific Reports

Advanced Neuroimaging Techniques and ApplicationsMultiple Sclerosis Research Studies

Cited by 35

New Alzheimer’s disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers

Ochiishi, T., Kaku, M., Kiyosue, K., Doi, M., Urabe, T., Hattori, N., Shimura, H., & Ebihara, T. (2019) · Scientific Reports

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 34

Accumulation of Somatic Mutation in Mitochondrial DNA and Atherosclerosis in Diabetic Patients

NOMIYAMA, T., TANAKA, Y., PIAO, L., HATTORI, N., UCHINO, H., WATADA, H., KAWAMORI, R., & OHTA, S. (2004) · Annals of the New York Academy of Sciences

Mitochondrial Function and PathologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 27

Neurocognitive and psychiatric disorders‐related axonal degeneration in Parkinson’s disease

Andica, C., Kamagata, K., Hatano, T., Saito, Y., Uchida, W., Ogawa, T., Takeshige‐Amano, H., Hagiwara, A., Murata, S., Oyama, G., et al. (2020) · Journal of Neuroscience Research

Advanced Neuroimaging Techniques and ApplicationsParkinson's Disease Mechanisms and Treatments

Cited by 26

Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features

Ikeda, A., Shimada, H., Nishioka, K., Takanashi, M., Hayashida, A., Li, Y., Yoshino, H., Funayama, M., Ueno, Y., Hatano, T., et al. (2019) · Movement Disorders

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 22

Genotype–phenotype correlations of cysteine replacement in CADASIL

Matsushima, T., Conedera, S., Tanaka, R., Li, Y., Yoshino, H., Funayama, M., Ikeda, A., Hosaka, Y., Okuzumi, A., Shimada, Y., et al. (2017) · Neurobiology of Aging

Cerebrovascular and genetic disordersIntracerebral and Subarachnoid Hemorrhage Research

Cited by 19